Form 4: McKesson EVP & CFO Britt J. Vitalone Trades Shares

McKesson Corporation's EVP & CFO, Britt J. Vitalone, reported transactions involving common stock and restricted stock units on May 21, 2026.

Summary

• Britt J. Vitalone, Executive Vice President & Chief Financial Officer of McKesson Corporation, engaged in stock transactions on May 21, 2026.
• Vitalone acquired 1,207 shares of common stock at a price of $0, with a reported value of $21,505.377.
• Additionally, 447 shares were disposed of for tax withholding purposes related to the vesting of Restricted Stock Units (RSUs), with a reported value of $766.5.
• Following these transactions, Vitalone beneficially owns 21,058.377 shares of common stock directly.
• Vitalone also holds 552.2473 shares indirectly through the McKesson Corporation 401(k) Retirement Savings Plan.
• The filing also notes the vesting schedule for RSUs, with one-third vesting on May 21, 2025, May 21, 2026, and the remaining one-third on May 21, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions and RSU vesting, which are standard disclosures and do not inherently signal positive or negative performance.

Positives

• The CFO's continued beneficial ownership of a significant number of shares (21,058.377 directly and 552.2473 indirectly) suggests confidence in the company's future.
• The RSU vesting schedule indicates a long-term incentive structure for management, aligning their interests with shareholders over time.

Negatives

• The disposal of 447 shares for tax withholding, while standard practice, represents a reduction in direct shareholding.
• The transaction code 'M' for acquisition and 'F' for disposal suggests a net change in holdings, though the acquisition is at $0 cost, likely related to RSU vesting.

Risks

• The filing does not explicitly mention any new risks or challenges.
• Potential future tax implications for management on vested RSUs could lead to further share disposals.

Future Outlook

The vesting schedule for RSUs indicates continued equity-based compensation for management through May 21, 2027, suggesting ongoing alignment with long-term company performance.

Management Comments

• The filing is a standard disclosure of insider transactions and does not contain direct management commentary.
• The explanation of responses clarifies that the 'M' transaction code represents an acquisition of shares at $0 cost, likely tied to RSU vesting, and the 'F' transaction code represents shares withheld for taxes.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing stock transactions by company insiders. These filings are crucial for understanding insider sentiment and potential shifts in beneficial ownership within the healthcare distribution sector.

Comparison to Industry Standards

• This filing is a standard SEC Form 4, which is a regulatory requirement for all U.S. public companies and their insiders, including those in the healthcare distribution industry.
• The practice of withholding shares to cover taxes upon RSU vesting is a common and accepted method across the industry.

Stakeholder Impact

• Shareholders: The transactions provide transparency into insider holdings and potential selling pressure (for tax withholding), but do not directly impact current share value.
• Employees: The RSU vesting schedule reinforces the company's use of equity as a long-term incentive for key personnel.
• Management: Britt J. Vitalone's direct and indirect ownership reflects his continued stake in the company's performance.

Next Steps

• The remaining one-third of the reported RSUs are scheduled to vest on May 21, 2027.
• Future Form 4 filings will be required for any subsequent transactions by Britt J. Vitalone.

Key Dates

Keywords

McKesson Corporation, MCK, Form 4, Insider Trading, Stock Transaction, Britt J. Vitalone, EVP & CFO, Restricted Stock Units, RSUs, Beneficial Ownership, Securities Exchange Act